Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANNABIDIOL Cause Product supply issue? 298 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Product supply issue have been filed in association with CANNABIDIOL (Epidiolex). This represents 1.6% of all adverse event reports for CANNABIDIOL.

298
Reports of Product supply issue with CANNABIDIOL
1.6%
of all CANNABIDIOL reports
1
Deaths
39
Hospitalizations

How Dangerous Is Product supply issue From CANNABIDIOL?

Of the 298 reports, 1 (0.3%) resulted in death, 39 (13.1%) required hospitalization, and 1 (0.3%) were considered life-threatening.

Is Product supply issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANNABIDIOL. However, 298 reports have been filed with the FAERS database.

What Other Side Effects Does CANNABIDIOL Cause?

Seizure (4,980) Hospitalisation (1,840) Off label use (1,636) Product use in unapproved indication (1,585) Diarrhoea (1,356) Death (1,115) Somnolence (1,005) Product dose omission issue (895) Drug ineffective (859) Fatigue (715)

What Other Drugs Cause Product supply issue?

SECUKINUMAB (357) LENALIDOMIDE (310) APREMILAST (266) HUMAN IMMUNOGLOBULIN G (169) OFATUMUMAB (149) ELTROMBOPAG OLAMINE (140) HUMAN C1-ESTERASE INHIBITOR (117) OXCARBAZEPINE (109) CARBAMAZEPINE (98) POMALIDOMIDE (92)

Which CANNABIDIOL Alternatives Have Lower Product supply issue Risk?

CANNABIDIOL vs CANNABIDIOL\HERBALS CANNABIDIOL vs CANNABIS SATIVA FLOWERING TOP CANNABIDIOL vs CANNABIS SATIVA SUBSP. INDICA TOP CANNABIDIOL vs CANRENOATE CANNABIDIOL vs CANRENOIC ACID

Related Pages

CANNABIDIOL Full Profile All Product supply issue Reports All Drugs Causing Product supply issue CANNABIDIOL Demographics